Document Detail

An update on peripartum cardiomyopathy.
MedLine Citation:
PMID:  21932958     Owner:  NLM     Status:  In-Data-Review    
Peripartum cardiomyopathy is a rare but potentially devastating complication of pregnancy. Although the definition of this condition has recently been revised by the Heart Failure Association of the European Society of Cardiology, the pathogenesis of peripartum cardiomyopathy is not well understood and relatively little is known about its incidence and prevalence. Hence, peripartum cardiomyopathy is often under-recognized in the clinical setting. A heightened awareness of this condition and its current management options is therefore warranted throughout primary and secondary care. The identification of the putative role of prolactin in the development and progression of this condition has been recently discovered, with preclinical work suggesting beneficial effects of prolactin antagonism. In this article, we review the literature regarding this condition including these recent advances.
Jonathan R Dalzell; Colette E Jackson; Roy S Gardner
Related Documents :
7246628 - Amniotic fluid phosphatidylglycerol: a potentially useful predictor of intrauterine gro...
7387938 - Screening for fetal risk with urinary oestrogen: creatinine ratio at 34 weeks.
15976088 - Developmental changes in diffusion anisotropy coincide with immature oligodendrocyte pr...
12499668 - Variability of autogamy-maturation pattern in genetically identical populations of para...
9746388 - Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990s.
9466188 - Pregnancy outcome after assisted fertilization--a short survey.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  9     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1155-60     Citation Subset:  IM    
Scottish Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow, G81 4HX, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better.
Next Document:  Nutritional and micronutrient determinants of idiopathic dilated cardiomyopathy: diagnostic and ther...